持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/09/15 | 8,050 | 8,050 | 7,910 | 7,980 | -80 | -1% | 35,500 |
2016/09/14 | 8,090 | 8,200 | 8,050 | 8,060 | -80 | -1% | 47,200 |
2016/09/13 | 8,070 | 8,190 | 8,070 | 8,140 | +70 | +0.9% | 59,200 |
2016/09/12 | 8,030 | 8,150 | 8,000 | 8,070 | ±0 | ±0% | 49,100 |
2016/09/09 | 8,130 | 8,160 | 8,030 | 8,070 | -70 | -0.9% | 29,600 |
2016/09/08 | 8,180 | 8,180 | 8,030 | 8,140 | -40 | -0.5% | 32,500 |
2016/09/07 | 8,010 | 8,280 | 8,000 | 8,180 | +130 | +1.6% | 71,700 |
2016/09/06 | 7,860 | 8,080 | 7,860 | 8,050 | +250 | +3.2% | 45,100 |
2016/09/05 | 7,760 | 7,840 | 7,720 | 7,800 | -10 | -0.1% | 30,500 |
2016/09/02 | 7,690 | 7,830 | 7,690 | 7,810 | +90 | +1.2% | 47,700 |
2016/09/01 | 7,230 | 7,740 | 7,230 | 7,720 | +570 | +8% | 130,400 |
2016/08/31 | 7,210 | 7,240 | 7,010 | 7,150 | -110 | -1.5% | 88,900 |
2016/08/30 | 7,230 | 7,290 | 7,110 | 7,260 | -10 | -0.1% | 168,800 |
2016/08/29 | 7,450 | 7,450 | 7,200 | 7,270 | -80 | -1.1% | 47,800 |
2016/08/26 | 7,380 | 7,420 | 7,300 | 7,350 | -80 | -1.1% | 50,800 |
2016/08/25 | 7,490 | 7,550 | 7,360 | 7,430 | -60 | -0.8% | 47,400 |
2016/08/24 | 7,430 | 7,530 | 7,380 | 7,490 | +120 | +1.6% | 53,900 |
2016/08/23 | 7,130 | 7,400 | 7,080 | 7,370 | +130 | +1.8% | 59,600 |
2016/08/22 | 7,150 | 7,410 | 7,080 | 7,240 | +20 | +0.3% | 53,800 |
2016/08/19 | 7,190 | 7,320 | 7,110 | 7,220 | -30 | -0.4% | 52,600 |
2016/08/18 | 7,320 | 7,450 | 7,230 | 7,250 | -220 | -2.9% | 43,700 |
2016/08/17 | 7,450 | 7,500 | 7,400 | 7,470 | -30 | -0.4% | 35,800 |
2016/08/16 | 7,650 | 7,650 | 7,460 | 7,500 | -160 | -2.1% | 29,400 |
2016/08/15 | 7,780 | 7,850 | 7,630 | 7,660 | -170 | -2.2% | 29,000 |
2016/08/12 | 7,730 | 7,840 | 7,630 | 7,830 | +220 | +2.9% | 44,500 |
2016/08/10 | 7,720 | 7,720 | 7,540 | 7,610 | +30 | +0.4% | 38,100 |
2016/08/09 | 7,480 | 7,600 | 7,450 | 7,580 | +110 | +1.5% | 30,600 |
2016/08/08 | 7,560 | 7,600 | 7,370 | 7,470 | -20 | -0.3% | 50,300 |
2016/08/05 | 7,610 | 7,650 | 7,390 | 7,490 | -50 | -0.7% | 35,000 |
2016/08/04 | 7,700 | 7,720 | 7,480 | 7,540 | -180 | -2.3% | 42,300 |
2016/08/03 | 8,010 | 8,020 | 7,710 | 7,720 | -290 | -3.6% | 32,800 |
2016/08/02 | 7,890 | 8,120 | 7,870 | 8,010 | +80 | +1% | 44,600 |
2016/08/01 | 7,870 | 7,990 | 7,750 | 7,930 | +80 | +1% | 56,400 |
2016/07/29 | 8,000 | 8,020 | 7,830 | 7,850 | -120 | -1.5% | 44,100 |
2016/07/28 | 8,020 | 8,140 | 7,970 | 7,970 | -50 | -0.6% | 29,100 |
2016/07/27 | 8,140 | 8,170 | 8,010 | 8,020 | -70 | -0.9% | 22,800 |
2016/07/26 | 8,100 | 8,170 | 8,010 | 8,090 | -30 | -0.4% | 34,500 |
2016/07/25 | 8,190 | 8,240 | 8,070 | 8,120 | -70 | -0.9% | 32,400 |
2016/07/22 | 8,100 | 8,210 | 8,100 | 8,190 | -10 | -0.1% | 23,300 |
2016/07/21 | 8,330 | 8,360 | 8,160 | 8,200 | -130 | -1.6% | 21,800 |
2016/07/20 | 8,210 | 8,360 | 8,210 | 8,330 | -30 | -0.4% | 50,600 |
2016/07/19 | 8,230 | 8,380 | 8,220 | 8,360 | ±0 | ±0% | 57,500 |
2016/07/15 | 8,580 | 8,590 | 8,330 | 8,360 | -230 | -2.7% | 45,500 |
2016/07/14 | 8,420 | 8,680 | 8,420 | 8,590 | +110 | +1.3% | 41,400 |
2016/07/13 | 8,810 | 8,810 | 8,450 | 8,480 | -220 | -2.5% | 61,100 |
2016/07/12 | 8,880 | 8,940 | 8,690 | 8,700 | -130 | -1.5% | 38,700 |
2016/07/11 | 8,700 | 8,940 | 8,660 | 8,830 | +270 | +3.2% | 37,400 |
2016/07/08 | 8,710 | 8,760 | 8,560 | 8,560 | -70 | -0.8% | 27,800 |
2016/07/07 | 8,600 | 8,900 | 8,590 | 8,630 | +20 | +0.2% | 31,200 |
2016/07/06 | 8,650 | 8,650 | 8,420 | 8,610 | -40 | -0.5% | 52,000 |
2001~
2050
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム